Lamb Weston to Announce Fourth Quarter and Full Fiscal Year 2026 Financial Results on July 24, 2026
Get Alerts LW Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.4%
Revenue Growth %: +0.6%
Join SI Premium – FREE
EAGLE, Idaho--(BUSINESS WIRE)-- Lamb Weston Holdings, Inc. (NYSE: LW) announced today it will report fourth quarter and full fiscal year 2026 financial results on July 24, 2026. The news release will be issued at approximately 8:00 a.m. ET, followed by a conference call at 9:00 a.m. ET.
The webcast and accompanying materials will be available on Lamb Weston’s Investor Relations page at https://investors.lambweston.com/news-events/events-and-presentations.
Alternatively, participants in the U.S. and Canada may access the conference call by dialing 1-800-330-6710; participants outside the U.S. and Canada should dial +1 213-279-1505. The conference ID is 9814300.
A rebroadcast of the conference call will be available later in the day at the same location.
About Lamb Weston
Lamb Weston is a leading supplier of frozen potato products to restaurants and retailers around the world. For more than 75 years, Lamb Weston has led the industry in innovation, introducing inventive products that simplify back-of-house management for its customers and make things more delicious for their customers. From the fields where Lamb Weston potatoes are grown to proactive customer partnerships, Lamb Weston always strives for more and never settles. Because, when we look at a potato, we see possibilities. Learn more about us at lambweston.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260624389111/en/
For more information, please contact:
Investors:
Debbie Hancock
[email protected]
Media:
Erin Gardiner
[email protected]
Source: Lamb Weston Holdings, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe upgrades AT&T to Outperform as improving fundamentals outweigh Starlink risk
- Thyora Therapeutics Launches to Build a Next-Generation Platform for Covalent Drug Discovery
- Tensormesh and AMD Collaborate to Empower Fewer GPUs to Serve More Models
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share